What is the appropriate starting dose of Vyvanse (lisdexamfetamine) for an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adult Starting Dosage for Vyvanse

The recommended starting dose of Vyvanse (lisdexamfetamine) for adults is 30 mg once daily in the morning. 1

Dosing Algorithm

Initial Dosing

  • Start at 30 mg once daily taken in the morning with or without food 1
  • Avoid afternoon doses due to insomnia risk 1

Titration Schedule

  • Increase in increments of 10 mg or 20 mg at approximately weekly intervals if symptom control is inadequate 1
  • Maximum recommended dose: 70 mg once daily 1
  • Clinical trials demonstrated efficacy across the 30-70 mg dose range, with all doses showing significant improvement over placebo 2

Administration Options

Vyvanse can be taken as:

  • Capsules swallowed whole, OR
  • Capsules opened and mixed with yogurt, water, or orange juice (consume entire mixture immediately), OR
  • Chewable tablets (must be chewed thoroughly before swallowing) 1

Important Clinical Considerations

Pretreatment Requirements

Before initiating Vyvanse, you must assess for:

  • Cardiac disease through careful history, family history of sudden death/ventricular arrhythmia, and physical exam 1
  • Baseline blood pressure and pulse 3
  • Family history of tics or Tourette's syndrome 1

Dose-Response Evidence

Research shows that higher doses (50-70 mg) produce greater ADHD symptom improvements compared to 30 mg, with effect sizes maintained from 2 to 14 hours post-dose 2, 4. However, patients with greater baseline symptom severity may benefit more from higher doses, particularly for hyperactive-impulsive symptoms 5. A 2024 meta-analysis found that unlicensed doses above 70 mg showed only small additional gains with increased adverse event risk 6, supporting adherence to the 70 mg maximum.

Special Populations

Renal Impairment:

  • Severe renal impairment (GFR 15-30): Maximum 50 mg daily 1
  • End-stage renal disease (GFR <15): Maximum 30 mg daily 1

Monitoring During Titration

  • Weekly assessment of ADHD symptoms using rating scales 3
  • Monitor for adverse events at each dose increment (most common: decreased appetite, dry mouth, insomnia) 2
  • Quarterly blood pressure and pulse checks once maintenance dose established 3

Common Pitfalls to Avoid

  • Do not divide doses - Vyvanse must be given as a single daily dose 1
  • Do not exceed 70 mg daily in routine practice - evidence suggests diminishing returns with increased adverse events 6
  • Do not assume non-response at lower doses means higher doses will work - if 70 mg is ineffective, consider switching medications rather than exceeding maximum dose 3
  • Account for drug interactions - acidifying agents (vitamin C) decrease blood levels while alkalinizing agents (sodium bicarbonate) increase levels; adjust dose accordingly 1

Response Timeline

Significant improvements typically occur within the first week of treatment at therapeutic doses 2, making weekly titration intervals appropriate for assessing response before dose escalation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.